To add to the discussion:
We have a number of positive employees who have been treated with BAM protocol, some under EUA down to age 18, as we are participating in the clinical trial.
Most became ill after receiving their first dose of vaccine
We are deferring the second dose of vaccine in these individuals for 90 days at present.
Laura
Laura L Radke, MD
Medical Director, F&MCW Occupational Health Services
Phone: 262-253-8197 | Fax: 262-253-5152 Cell Phone: 414-530-0723
E-mail:
laura.radke@froedtert.com
Froedtert & the Medical College of Wisconsin Workforce Health / North Hills Health Center Building B First Floor
W129 N7055 Northfield Dr.
Menomonee Falls, WI 53051
From: MCOH-EH <mcoh-eh-bounces+laura.radke=froedtert.com@mylist.net>
On Behalf Of Abhijay Karandikar via MCOH-EH
Sent: Saturday, January 9, 2021 5:29 PM
To: mcoh-eh@mylist.net; Jeremy Biggs <jerbiggs@yahoo.com>
Cc: Abhijay Karandikar <dr_abhik@yahoo.com>
Subject: Re: [MCOH-EH] COVID Vaccination Dose #2 in employees who become positive after dose #1
Our recommendations are similar and based on current CDC guidelines. An employee can receive the COVID vaccine as long as they are not currently
infected and/or symptomatic and as long as they have met our system criteria for ending isolation (10 days have passed since symptoms first appeared and at least 24 hours have passed since last fever or 10 days have passed since the date of a positive test
in an asymptomatic employee).
As Melanie and others have stated, it is prudent to adhere to the 21/28 day timeline of the second dose as much as possible, depending on the vaccine, since those were the
conditions under which clinical trials were conducted and efficacy studied and measured.
An employee may defer receiving vaccination for 90 days after a confirmed COVID-19 infection if they have not received any dose of the vaccine; that is their personal choice.
Abhijay
Abhijay P. Karandikar, MD, MPH, FACOEM
Chief, Section of Occupational Medicine & Employee Health
Reading Hospital
On Friday, January 8, 2021, 01:19:01 PM EST, Jeremy Biggs via MCOH-EH <mcoh-eh@mylist.net> wrote:
What are your policies for the following:
Employee has first vaccine and then becomes positive for COVID before the second dose. We have decided, based on the CDC
site, COVID before or after 1st dose and before 2nd, don't need to interrupt the schedule, reschedule as long as symptoms resolved and at least 10 days from symptom onset or positive test in an asymptomatic employee.
I have talked with other institutions and some are postponing the second dose for 90 days from symptom onset or positive test in an asymptomatic positive. This
they have said is to use the vaccine for others.
Anyone else doing anything different?
Jeremy Biggs MD MSPH FACOEM
Associate Professor
PPE “Czar”
University of Utah, Department of Family and Preventive Medicine
Rocky Mountain Center for Occupational and Environmental Health
Medical Director Rocky Mountain Specialty Services Clinic
Medical Director of the University Hospital and University Campus Employee Clinics
Medical Director of Occupational Medicine and Health, EHS and University Hospital and Clinics
---------------------------------------
The MCOH-EH List has always been moderated by members of the ACOEM Medical Center Occupational Health Section. It is currently moderated by Joe Fanucchi MD FACOEM.
List membership is free, but only subscribers may post to the list.
To post send messages to: mcoh-eh@mylist.net
To become a subscriber, or to change your subscription options (turn off email while you're on vacation, etc):
http://www.mcoh-eh.net
MediTrax / Occupational Health Systems, Inc. provides financial support to ensure the list remains a free resource for the occupational health community.
---------------------------------------
List archives (public):
http://mylist.net/archives/mcoh-eh/
---------------------------------------
Send administrative requests to:
drjoe@meditrax.com
---------------------------------------
When replying to a message, PLEASE delete all footers, and all messages to which you're NOT replying.